Before starting GLP-1 treatment , inform your GP about: Current or previous anxiety disorders , including generalised anxiety disorder, panic disorder, social anxiety, or health anxiety Other mental health conditions such as depression, eating disorders, or obsessive-compulsive disorder Current psychiatric medications , as weight loss may affect medication requirements though GLP-1 medications themselves have few direct drug interactions Previous experiences with weight loss or diabetes medications and any associated mood changes Your support network and coping strategies for managing stress and anxiety Your GP can help establish baseline mental health status and develop a monitoring plan
What Cases Are We Not Accepting
The trial measures major adverse cardiovascular events (MACE), including heart attack, stroke, and cardiovascular death
86 VilsbllTBainSCLeiterLALingvayIMatthewsDSimRet al
Both drugs can lower the risk of a heart attack, stroke, or death in adults with Type 2 diabetes and cardiovascular disease (or who are at risk of developing cardiovascular disease)
